| Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy (NCT02914314) | Eisai Inc. | 2017-02-20 |
| Safety and Efficacy of TOP1630 for Dry Eye Syndrome (NCT03088605) | ORA, Inc. | 2017-02-20 |
| A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease (NCT03056742) | Stempeutics Research Pvt Ltd | 2017-02-20 |
| Clinical Trial With MSC for Graft Versus Host Disease Treatment (NCT02687646) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2017-02-20 |
| A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke (NCT02928393) | Hoffmann-La Roche | 2017-02-20 |
| Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR) (NCT02958163) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2017-02-20 |
| A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease (NCT02915783) | Eisai Inc. | 2017-02-20 |
| Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE) (NCT02801695) | Nantes University Hospital | 2017-02-20 |
| Study of DC-CTL Combined With CIK for Advanced Solid Tumor (NCT03047525) | Xiaoyi Huang | 2017-02-20 |
| Study to Evaluate Safety/Efficacy of a Single Preop Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery (NCT02807428) | Adynxx, Inc. | 2017-02-20 |
| Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma (NCT03042182) | Immunitor LLC | 2017-02-20 |
| Study to Justify Steroid Use in Preterm Neonates to Prevent Bronchopulmonary Dysplasia (NCT03035214) | Maadi Military Hospital | 2017-02-19 |
| Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma (NCT03107962) | Mingzhi Zhang | 2017-02-19 |
| An Acute Migraine Factorial Study (NCT06245902) | Allodynic Therapeutics, Inc | 2017-02-18 |
| Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine (NCT03061734) | Allodynic Therapeutics, Inc | 2017-02-18 |
| Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA (NCT03119701) | Faron Pharmaceuticals Ltd | 2017-02-18 |
| The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition (NCT03068442) | Scott Mcnally | 2017-02-17 |
| PemVin vs Vin in Previously Treated Metastatic Breast Cancer (NCT03242616) | Seoul National University Hospital | 2017-02-17 |
| Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI (NCT02929667) | Rup Kamal Sainju | 2017-02-16 |
| Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder (NCT02901548) | H. Lee Moffitt Cancer Center and Research Institute | 2017-02-16 |
| The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy (NCT02815540) | Gillette Children's Specialty Healthcare | 2017-02-16 |
| A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma (NCT03006848) | St. Jude Children's Research Hospital | 2017-02-16 |
| Uptake and Biodistribution of 89Zirconium-labeled Ipilimumab in Ipilimumab Treated Patients With Metastatic Melanoma (NCT03313323) | Amsterdam UMC, location VUmc | 2017-02-16 |
| Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer (NCT03037437) | The University of Texas Health Science Center at San Antonio | 2017-02-16 |
| Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor (NCT03069469) | Deciphera Pharmaceuticals, LLC | 2017-02-16 |
| Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus (NCT03025906) | Xuanwu Hospital, Beijing | 2017-02-16 |
| A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption (NCT03115567) | Northwestern University | 2017-02-16 |
| Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe (NCT04296149) | European Institute of Oncology | 2017-02-16 |
| Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies (NCT02991898) | Masonic Cancer Center, University of Minnesota | 2017-02-16 |
| BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects (NCT03103581) | Braintree Laboratories | 2017-02-16 |
| An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma (NCT03029780) | Bristol-Myers Squibb | 2017-02-16 |
| Autologous Platelet Lysate in Corneal Epithelial Defects (NCT02979912) | Hanan Jafar | 2017-02-16 |
| Pain Free Laceration Repairs Using Intra-nasal Ketamine (NCT03053947) | Evelyne D.Trottier | 2017-02-16 |
| Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery (NCT02760030) | Ohio State University Comprehensive Cancer Center | 2017-02-16 |
| Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder (NCT03056053) | Idorsia Pharmaceuticals Ltd. | 2017-02-15 |
| Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons (NCT02572323) | University of California, San Diego | 2017-02-15 |
| A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML) (NCT03040401) | Vastra Gotaland Region | 2017-02-15 |
| Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma (NCT02831933) | Eric Bernicker, MD | 2017-02-15 |
| Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer (NCT03126071) | Jiangsu Cancer Institute & Hospital | 2017-02-15 |
| Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma (NCT02875132) | Chinese University of Hong Kong | 2017-02-15 |
| A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (NCT02952534) | pharmaand GmbH | 2017-02-15 |
| A Prospective, Interventional Study Assessing Response to Cytarabine, Daunorubicin and Etoposide (ADE) for First Relapse of Paediatric Acute Myeloid Leukemia (NCT03053206) | All India Institute of Medical Sciences | 2017-02-15 |
| A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of Bladder (NCT03061630) | Samsung Medical Center | 2017-02-15 |
| Study of LM11A-31-BHS in Mild-moderate AD Patients (NCT03069014) | PharmatrophiX Inc. | 2017-02-15 |
| Anticaries Effect of Xylitol,Probiotic and Chlorhexidine Mouth Rinses Among Individuals at High Risk (NCT04399161) | Dr. Krupa NC | 2017-02-15 |
| Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1 (NCT03090971) | Fundação Educacional Serra dos Órgãos | 2017-02-15 |
| Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC (NCT03046992) | Yuhan Corporation | 2017-02-15 |
| Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer (NCT02730429) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2017-02-15 |
| Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure (NCT02997995) | UNICANCER | 2017-02-15 |
| Propranolol for Sleep Apnea Therapy (NCT03049306) | Johns Hopkins University | 2017-02-15 |
| PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies (NCT03030001) | Ningbo Cancer Hospital | 2017-02-15 |
| Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C (NCT03416491) | Kawin Technology Share-holding Co., Ltd. | 2017-02-15 |
| SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma (NCT02807181) | Sirtex Medical | 2017-02-14 |
| Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib (NCT02713763) | Grupo Espanol de Tumores Neuroendocrinos | 2017-02-14 |
| A Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type (NCT02927925) | Janssen Research & Development, LLC | 2017-02-14 |
| Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer (NCT02923180) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-02-14 |
| A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations (NCT02962960) | AstraZeneca | 2017-02-14 |
| Spinal Cord Injury Neuroprotection With Glyburide (NCT02524379) | Ohio State University | 2017-02-14 |
| Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray (NCT03223896) | Finnish Institute for Health and Welfare | 2017-02-14 |
| Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis (NCT03059446) | Tobira Therapeutics, Inc. | 2017-02-14 |
| Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma (NCT02816021) | M.D. Anderson Cancer Center | 2017-02-14 |
| Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients (NCT03053856) | Samsung Medical Center | 2017-02-14 |
| Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment (NCT03011034) | Janssen Research & Development, LLC | 2017-02-14 |
| Ketamine and Nitroprusside for Depression (NCT03102736) | Icahn School of Medicine at Mount Sinai | 2017-02-14 |
| Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma (NCT03015896) | David Bond, MD | 2017-02-14 |
| Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) (NCT02955069) | Novartis Pharmaceuticals | 2017-02-14 |
| A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period (NCT03116698) | Dr. Reddy's Laboratories Limited | 2017-02-14 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects (NCT03020745) | GlaxoSmithKline | 2017-02-14 |
| A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis (NCT03004846) | GlaxoSmithKline | 2017-02-13 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy (NCT02987114) | PhytoTech Therapeutics, Ltd. | 2017-02-13 |
| BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma (NCT02872259) | Haukeland University Hospital | 2017-02-13 |
| Denosumab as an add-on Neoadjuvant Treatment (GeparX) (NCT02682693) | GBG Forschungs GmbH | 2017-02-13 |
| Clemizole HCl for Subjects With Hepatocellular Carcinoma (NCT03069508) | Eiger Group International, Inc. | 2017-02-13 |
| Varenicline Treatment for Cannabis Use Disorder (NCT02892110) | Medical University of South Carolina | 2017-02-13 |
| Intrathecal Tetanus Immunoglobulin to Treat Tetanus (NCT02999815) | Oxford University Clinical Research Unit, Vietnam | 2017-02-13 |
| Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis. (NCT03667131) | University of Guadalajara | 2017-02-13 |
| Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer (NCT03043599) | H. Lee Moffitt Cancer Center and Research Institute | 2017-02-13 |
| Effects of 2% IDL Lotion on Skin Hydration and Transepidermal Water Loss in Females With Dry Skin (NCT04253704) | Shyla Cantor | 2017-02-13 |
| Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer (NCT03595644) | Tongji Hospital | 2017-02-12 |
| Evaluation of Doxazosin to Alter the Abuse of Oxycodone (NCT03415581) | New York State Psychiatric Institute | 2017-02-12 |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall (NCT03651375) | Maria Sklodowska-Curie National Research Institute of Oncology | 2017-02-11 |
| Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma (NCT02928029) | Bayer | 2017-02-10 |
| Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor (NCT02678533) | Assistance Publique - Hôpitaux de Paris | 2017-02-10 |
| Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran (NCT03193944) | Alborz Medical University | 2017-02-10 |
| Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression (NCT03052478) | Samsung Medical Center | 2017-02-10 |
| Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity (NCT03013543) | Rhythm Pharmaceuticals, Inc. | 2017-02-10 |
| Curcumin Supplement in Nonalcoholic Fatty Liver Patients (NCT02908152) | National Nutrition and Food Technology Institute | 2017-02-10 |
| Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity (NCT03062462) | First Affiliated Hospital of Harbin Medical University | 2017-02-10 |
| Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC (NCT03044626) | AIO-Studien-gGmbH | 2017-02-10 |
| Application of Photodynamic Therapy and Diode Laser for Endodontic Therapy of Young Permanent Teeth (NCT03074136) | Association of Paediatric and Preventive Dentists of Serbia | 2017-02-10 |
| Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant (NCT03078010) | Memorial Sloan Kettering Cancer Center | 2017-02-10 |
| Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074 (NCT02957617) | Biogen | 2017-02-10 |
| INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) (NCT02977780) | David Reardon, MD | 2017-02-09 |
| Lidocaine in ERAS for FESS (NCT03047070) | Assiut University | 2017-02-09 |
| Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer (NCT02635360) | Linda R Duska | 2017-02-09 |
| A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer (NCT03042702) | Innovation Pharmaceuticals, Inc. | 2017-02-09 |
| Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects (NCT02991859) | GlaxoSmithKline | 2017-02-09 |
| A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application (NCT03052842) | Armata Pharmaceuticals, Inc. | 2017-02-09 |
| A Study of Abemaciclib in Recurrent Glioblastoma (NCT02981940) | Dana-Farber Cancer Institute | 2017-02-09 |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (NCT03058289) | Intensity Therapeutics, Inc. | 2017-02-09 |